Natasha Preece

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Medicine, Dermatology, Oncology +13

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma

María Romina Girotti, Filipa M. Lopes, Natasha Preece et al. · Cancer Cell · 2014 · 209 citations · Full text

Medicine, Cancer Biology, Oncology +17

Contrasting effects of sunitinib within in vivo models of metastasis

Jonathan Welti, Thomas Powles, Shane Foo et al. · Angiogenesis · 2012 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Victoria L. Bridgeman, Elaine Y. Wan, Shane Foo et al. · Molecular Cancer Therapeutics · 2015 · 49 citations

Medicine, Oncology, Pharmacology +17

Novel Hinge Binder Improves Activity and Pharmacokinetic Properties of BRAF Inhibitors

Alfonso Zambon, Delphine Ménard, Bart M. J. M. Suijkerbuijk et al. · Journal of Medicinal Chemistry · 2010 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +13